Active Global Funds: Performance & Attribution 2025

Global Equity

Active Global Funds: Performance & Attribution 2025

January 8th 2026

Key Data Points

  • Strong Absolute Returns, Weak Relative Results: Global equity funds returned 18.8% in 2025, but only 27.1% outperformed the SPDR ACWI ETF, which gained 22.8%.
  • Value-Led Outperformance at the Top: Top performers were driven by Value strategies, with the cohort averaging 26.1% — well ahead of the peer group.
  • Tech and US Exposure Dominated: Technology contributed 5.6% to returns, with the US accounting for 8.4% overall — reinforcing their central role in portfolio performance.
  • Benchmark Beats on Stock Selection: US Tech stock selection was the biggest source of underperformance, despite the correct underweight call.
  • Underweights in US Consumer Discretionary and Energy, and overweights in Taiwan Tech, added modest outperformance.
  • Long-Term Struggles Continue: 2025 marked the fifth straight year of underperformance vs. the benchmark; the ETF’s 10-year lead now stands at 48.5%.

A Solid Year, but the Benchmark Spoils the Party
On the surface, 2025 delivered compelling returns for Global equity funds, with the average fund posting an 18.8% gain — a solid outcome in its own right. Standout performers like Artemis Global Income and Redwheel Global Intrinsic Value finished the year with returns exceeding 40%, fueled by a pronounced Value tailwind that lifted the entire Style group. In fact, the Value cohort outpaced the broader fund universe with an average return of 26.1%.

Yet, perhaps the most striking figure comes from the benchmark: the SPDR ACWI ETF returned 22.8% in 2025, comfortably ahead of the average active manager. Only 27.1% of funds surpassed this benchmark return, underscoring an ongoing challenge for active strategies in the global equity space.

Breaking Down the 2025 Return: Tech and the US Take the Lead
The 18.8% average return for active Global equity funds in 2025 can be unpacked by examining the underlying exposures across sectors and countries, based on active managers’ aggregate holdings. Technology stood out as the dominant driver, contributing 5.6 percentage points to overall returns — a reflection of both strong performance in the sector and its outsized weighting in portfolios. Financials added a further 3.9%, while Industrials and Communication Services contributed 3.1% and 2.2%, respectively.

At the country level, the USA — particularly through its exposure to Technology — accounted for 8.4% of the total return. EMEA delivered a more muted, but still material, contribution of just under 7%. On the downside, Danish Health Care shaved off 0.26% from performance — the only meaningful drag in an otherwise strong year for global allocations.

Stock-Level Influence: A Broad Base of Winners, Few Detractors
At the stock level, returns in 2025 were driven by a wide range of contributors, with gains led by key members of the “Mag 8” alongside strong performances from TSMC and Samsung Electronics. The breadth of positive contributions was notable, with the top 10 contributors accounting for just 27% of total fund returns for the year — underscoring the diversified nature of stock-level performance.

Detractors, by contrast, were fewer and less impactful. The ratio of stocks with positive versus negative contributions stood at roughly 2:1. Among the laggards, Novo Nordisk led the losses with a 39.4% decline, followed by UnitedHealth Group at -33% — the most significant individual drags on performance.

Performance Attribution – Where Did the Losses Come From?
The chart below highlights the main sources of outperformance and underperformance versus the benchmark at the country/sector level. The largest single driver of fund losses versus the benchmark was poor stock selection in US Technology.  The underweight call was the correct one, but individual over and underweights were misplaced and the benchmark won out.  We mustn’t understate the influence on Cash holding on Global performance, which during strong markets are an obvious drag – last year costing the average manager 0.5%.  

Pockets of outperformance were smaller in magnitude, with the US Consumer Discretionary underweight leading the winners, alongside Taiwan Tech Overweights and US Energy Underweights.

Stock Attribution
Active Global managers made marginal gains from their underweight in Apple, alongside overweights in TSMC and ASML, and smaller contributions from underperformers like Costco and Berkshire Hathaway.

But losses outweighed gains. Underweights in NVIDIA and Alphabet — along with smaller underweights in high-return names like Palantir and Micron — hurt performance versus the benchmark. On top of that, overweights in Novo Nordisk, Keyence Corp, and London Stock Exchange further extended relative losses.

Long-Term Performance: Benchmark dominance persists, but for how long?
This year’s underperformance marks the fifth consecutive year active Global equity funds have lagged the MSCI ACWI ETF — and ranks as the third-largest relative loss since 2012. The ETF has now landed in the top third of the fund universe for three straight years, with its 10-year return sitting a substantial 48.5% ahead of the average active manager.

For those who have managed to outperform, this backdrop offers compelling evidence to support fund marketing and asset gathering — highlighting just how rare benchmark-beating performance has become.

For the rest, there’s perhaps some consolation in the fact that US Technology continues to dominate benchmark returns. If that trend were to reverse or fade, the relative landscape could shift. Still, the consistency of underperformance makes it clear: the challenge of beating the passive default has rarely been higher.

Performance & Attribution Report

Click the link opposite for full charts and data detailing the drivers of 2025 performance, along with a review of 3-, 5-, and 10-year results across the active Global peer group.

Terms and Conditions

Investor Positioning Report — Copley Fund Research Ltd  ·  Last updated: July 2026  ·  Registered in England and Wales

1. Who we are

Copley Fund Research Ltd provides proprietary institutional fund intelligence to listed companies and investor relations professionals. These terms govern every purchase of an Investor Positioning Report. By completing a purchase you confirm you have read, understood, and agreed to these terms in full.

2. What you are purchasing

The Investor Positioning Report is a bespoke PDF report mapping the institutional fund universe around your stock. It covers current investors, past investors, competitor investors, and white space investors. Every report is built from scratch for the specific company ordered and is not a standardised or templated product.

3. Delivery and process

Following payment or invoice issuance, Copley Fund Research will contact you within one working day to agree your competitor set. Production begins once the competitor set is confirmed in writing. The completed report will be released to you within 48 hours of production starting, provided payment has been received in full; where payment is outstanding, the report will be withheld until payment clears. If the requested company falls outside our covered fund universes, or a competitor set cannot be agreed, Copley Fund Research will issue a full refund or cancel the outstanding invoice.

4. Competitor set agreement

The competitor set is agreed with you in writing prior to production, and the report is built to that agreed specification. Requests to amend the competitor set after delivery, based on a change of preference rather than an error, may be treated as a new order.

5. Refund policy

Because each report is produced individually for your company, orders are non-refundable once production has begun, except as set out in clauses 3 and 5a below. By purchasing, you agree not to dispute the charge with your card provider on the basis that the service was not as described, provided the report has been delivered to the agreed specification or corrected under clause 5a.

5a. Quality remedy

If a delivered report contains a material error caused by Copley Fund Research — for example, an incorrect company analysed, a competitor omitted from the agreed set, or content missing from the specification in clause 2 — Copley Fund Research will correct and redeliver the report at no additional charge, within a reasonable timeframe. This is your sole remedy for such errors.

6. Data and accuracy

All fund positioning data in the report reflects holdings as disclosed at the most recently available reporting date at the time of compilation. The timing of fund holdings disclosures is determined by regulatory requirements applicable to each fund and is outside the control of Copley Fund Research Ltd. This data may not reflect current fund positions. Copley Fund Research takes reasonable care to ensure accuracy but makes no warranty, express or implied, as to the completeness or current accuracy of the underlying data — though this does not affect the quality remedy in clause 5a for errors in how that data was analysed or presented. Past fund positioning is not indicative of future fund behaviour or investment decisions.

7. Not investment advice

The Investor Positioning Report is produced for investor relations intelligence purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy, hold, or sell any security. The data reflects historical fund positioning and must not be relied upon as a prediction of future fund behaviour or investment decisions. Copley Fund Research Ltd is not authorised or regulated by the Financial Conduct Authority for the provision of investment advice.

8. Permitted use and confidentiality

The report is licensed for internal use by the purchasing organisation only. You may share it with employees and directors of your organisation. You may not: reproduce, redistribute, publish, or resell the report or any part of it; share it with any third party outside your organisation without prior written consent; use the fund or portfolio manager names contained in the report to approach those individuals on behalf of Copley Fund Research or in a manner that could damage Copley Fund Research's relationships with those funds; or use the data for any purpose other than your own investor relations strategy. The data, analysis, and methodology contained in the report are the intellectual property of Copley